{"title":"Risk Factors for Death from Heart Disease in Elderly Colon Cancer Patients with Liver Metastasis.","authors":"Yuan Wu, Min-Hang Zhou","doi":"10.31557/APJCP.2024.25.12.4217","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Colon cancer is one of the most frequently diagnosed cancers worldwide. The study aimed to identify the risk factors of death from heart disease in the elderly colon cancer patients with liver metastasis.</p><p><strong>Methods: </strong>All data of the retrospective study were retrieved from database of the Surveillance, Epidemiology, and End Results between 2000 and 2020. Odds ratio (OR) and the corresponding 95% confidence intervals (CIs) were calculated by using logistic regression model.</p><p><strong>Results: </strong>A total of 14322 elderly colon cancer patients with liver metastasis were identified. Out of them, 288 cases died of heart diseases, and 2001 cases were alive. In multivariate logistic analysis, the significant predictors for heart disease death were old age (OR = 1.06, p = 0.000), other histologic type besides adenocarcinoma (OR = 1.68, p = 0.004) and tumor size ≥ 5cm (OR = 1.89, p = 0.000). The protective factors were metastases besides liver (OR = 0.70, p = 0.027), surgery (OR = 0.64, p = 0.001) and chemotherapy (OR = 0.23, p = 0.000).</p><p><strong>Conclusion: </strong>Among elderly colon cancer with liver metastases, it is crucial to identify the risk factors and adopt preventive methods and appropriate treatment, which may enhance the quality of patient care and prolong patients' survival.</p>","PeriodicalId":55451,"journal":{"name":"Asian Pacific Journal of Cancer Prevention","volume":"25 12","pages":"4217-4221"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Pacific Journal of Cancer Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31557/APJCP.2024.25.12.4217","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Colon cancer is one of the most frequently diagnosed cancers worldwide. The study aimed to identify the risk factors of death from heart disease in the elderly colon cancer patients with liver metastasis.
Methods: All data of the retrospective study were retrieved from database of the Surveillance, Epidemiology, and End Results between 2000 and 2020. Odds ratio (OR) and the corresponding 95% confidence intervals (CIs) were calculated by using logistic regression model.
Results: A total of 14322 elderly colon cancer patients with liver metastasis were identified. Out of them, 288 cases died of heart diseases, and 2001 cases were alive. In multivariate logistic analysis, the significant predictors for heart disease death were old age (OR = 1.06, p = 0.000), other histologic type besides adenocarcinoma (OR = 1.68, p = 0.004) and tumor size ≥ 5cm (OR = 1.89, p = 0.000). The protective factors were metastases besides liver (OR = 0.70, p = 0.027), surgery (OR = 0.64, p = 0.001) and chemotherapy (OR = 0.23, p = 0.000).
Conclusion: Among elderly colon cancer with liver metastases, it is crucial to identify the risk factors and adopt preventive methods and appropriate treatment, which may enhance the quality of patient care and prolong patients' survival.
期刊介绍：
Cancer is a very complex disease. While many aspects of carcinoge-nesis and oncogenesis are known, cancer control and prevention at the community level is however still in its infancy. Much more work needs to be done and many more steps need to be taken before effective strategies are developed. The multidisciplinary approaches and efforts to understand and control cancer in an effective and efficient manner, require highly trained scientists in all branches of the cancer sciences, from cellular and molecular aspects to patient care and palliation.
The Asia Pacific Organization for Cancer Prevention (APOCP) and its official publication, the Asia Pacific Journal of Cancer Prevention (APJCP), have served the community of cancer scientists very well and intends to continue to serve in this capacity to the best of its abilities. One of the objectives of the APOCP is to provide all relevant and current scientific information on the whole spectrum of cancer sciences. They aim to do this by providing a forum for communication and propagation of original and innovative research findings that have relevance to understanding the etiology, progression, treatment, and survival of patients, through their journal. The APJCP with its distinguished, diverse, and Asia-wide team of editors, reviewers, and readers, ensure the highest standards of research communication within the cancer sciences community across Asia as well as globally.
The APJCP publishes original research results under the following categories:
-Epidemiology, detection and screening.
-Cellular research and bio-markers.
-Identification of bio-targets and agents with novel mechanisms of action.
-Optimal clinical use of existing anti-cancer agents, including combination therapies.
-Radiation and surgery.
-Palliative care.
-Patient adherence, quality of life, satisfaction.
-Health economic evaluations.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
